On February 6, 2015, the U.S. Food and Drug Administration (FDA) issued a revised draft guidance titled Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback